Consolidated Statements of Changes in Equity $ in Thousands |
USD ($)
shares
|
Opening balance after adjustment, cumulative effect at date of initial application
USD ($)
|
Share capital
USD ($)
shares
|
Share capital
Opening balance after adjustment, cumulative effect at date of initial application
USD ($)
shares
|
Contributed surplus
USD ($)
|
Contributed surplus
Opening balance after adjustment, cumulative effect at date of initial application
USD ($)
|
Accumulated deficit
USD ($)
|
Accumulated deficit
Opening balance after adjustment, cumulative effect at date of initial application
USD ($)
|
Foreign currency reserve
USD ($)
|
Foreign currency reserve
Opening balance after adjustment, cumulative effect at date of initial application
USD ($)
|
DSUs
USD ($)
|
DSUs
Share capital
USD ($)
shares
|
DSUs
Contributed surplus
USD ($)
|
RSUs
USD ($)
shares
|
RSUs
Share capital
USD ($)
shares
|
RSUs
Contributed surplus
USD ($)
|
|||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beginning balance (in shares) at Dec. 31, 2021 | shares | 297,700,295 | ||||||||||||||||||
| Beginning balance at Dec. 31, 2021 | $ 1,327,017 | $ 2,416,256 | $ 297,819 | $ (1,388,779) | $ 1,721 | ||||||||||||||
| Changes in Stock Holders Equity [Roll Forward] | |||||||||||||||||||
| Net loss | (173,494) | [1] | (173,494) | ||||||||||||||||
| Deferred share consideration related to acquisition (in shares) | shares | 112,451 | ||||||||||||||||||
| Deferred share consideration related to acquisition | $ (20) | $ 1,762 | (1,782) | ||||||||||||||||
| Redeemed/exercised (in shares) | shares | 304,635 | 304,635 | 58,990 | 217,832 | 217,832 | ||||||||||||||
| Redeemed/exercised | $ 916 | $ 1,349 | (433) | $ (753) | $ 244 | $ (997) | $ (2,466) | $ 785 | $ (3,251) | ||||||||||
| Share-based compensation | 9,408 | 9,408 | 753 | $ 2,466 | |||||||||||||||
| Other comprehensive income (loss): | |||||||||||||||||||
| Defined benefit plan actuarial gain | 1,514 | [1] | 1,514 | ||||||||||||||||
| Foreign currency translation for foreign operations | $ (3,211) | [1] | (3,211) | ||||||||||||||||
| Ending balance (in shares) at Dec. 31, 2022 | shares | 298,394,203 | 298,394,203 | |||||||||||||||||
| Ending balance at Dec. 31, 2022 | $ 1,158,911 | $ 1,158,911 | $ 2,420,396 | $ 300,764 | $ (1,560,759) | $ (1,490) | |||||||||||||
| Changes in Stock Holders Equity [Roll Forward] | |||||||||||||||||||
| Net loss | (177,716) | (177,716) | |||||||||||||||||
| Deferred share consideration related to acquisition (in shares) | shares | 224,902 | ||||||||||||||||||
| Deferred share consideration related to acquisition | $ (15) | $ 3,053 | (3,068) | ||||||||||||||||
| Redeemed/exercised (in shares) | shares | 152,120 | 152,120 | 31,736 | 132,745 | 132,745 | ||||||||||||||
| Redeemed/exercised | $ 335 | $ 504 | (169) | (171) | $ 194 | $ (365) | $ (585) | $ 1,494 | $ (2,079) | ||||||||||
| Share-based compensation | 10,959 | 10,959 | $ 171 | $ 585 | |||||||||||||||
| Other comprehensive income (loss): | |||||||||||||||||||
| Defined benefit plan actuarial gain | 970 | 970 | |||||||||||||||||
| Foreign currency translation for foreign operations | $ (1,472) | (1,472) | |||||||||||||||||
| Ending balance (in shares) at Dec. 31, 2023 | shares | 298,935,706 | 298,935,706 | |||||||||||||||||
| Ending balance at Dec. 31, 2023 | $ 991,216 | $ 2,425,641 | $ 306,042 | $ (1,737,505) | $ (2,962) | ||||||||||||||
| |||||||||||||||||||